The global motorized thrombectomy devices market was valued at US$459.267 million in 2017 and is projected to expand at a CAGR of 6.43% over the forecast period to reach US$667.541 million by 2023. The market growth is attributed to the rapidly increasing geriatric population and growing incidence of cardiovascular diseases in many regions across the globe. Increasing demand for minimally invasive procedures has further fueled the market growth for motorized thrombectomy devices. Increased reliability and convenience offered by mechanical thrombectomy devices, as compared to their manual equivalents, is contributing to their increased adoption worldwide. Substantial amounts are continuously being funneled into research and development to make these devices more advanced which will further augment the market growth. North America accounts for the largest market share of the global motorized thrombectomy devices market owing to the continuous research and high adoption rate for advanced technologies in healthcare industry. Asia Pacific is expected to show the highest CAGR over the projected period as a result of increasing investments by key market players into the healthcare industry.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the motorized thrombectomy devices value chain. Last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global motorized thrombectomy devices market.

Major industry players profiled as part of the report are Medtronic, Bayer AG, Boston Scientific Corporation, and Stryker among others.

Segmentation
The global motorized thrombectomy devices market has been analyzed through following segments:

By Architecture
  • ·Open Systems
  • ·Closed Systems
By Field Strength
  • ·Low Field Strength
  • ·Mid Field Strength
  • ·High Field Strength
By Application
  • ·Brain and Neurological
  • ·Spine and Musculoskeletal
  • ·Abdominal
  • ·Coronary
  • ·Pulmonary
By Geography

·North America
  • ·United States
  • ·Canada
  • ·Others
·Europe
  • ·Germany
  • ·France
  • ·United Kingdom
  • ·Others
·Asia Pacific
  • ·Japan
  • ·China
  • ·India
  • ·Others
  • Rest of the World